Home » Topics » Regulatory » Patents

Patents
RSS

Bayer investigates CETP inhibitors as hypolipidemic/antiatherosclerotic agents

April 1, 1998

Antibacterial quinolone carboxylic acids prepared at Bayer

April 1, 1998

Novel antiosteoporotic compound discovered by AHP

April 1, 1998

Anticoagulants in development at DuPont Merck

April 1, 1998

Antiarrhythmic Na+/H+ exchange inhibitors prepared by Hoechst

March 31, 1998

Focus on agents for estrogen deprivation continues at Lilly

March 30, 1998

SKB develops new agents for osteoporosis and related disorders

March 30, 1998

New ocular agents described by Novartis

March 30, 1998

Adenosine derivatives for cardiovascular, lipid disorders

March 30, 1998

Cytokine inhibitors claimed by Novo Nordisk for diabetes and other disorders

March 30, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.